GREAT - Good Response With Appropriate Treatment
NCT02293785
·
clinicaltrials.gov ↗
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Cancer Pain
Neoplasms
Interventions
DRUG:
Oxycodone-Naloxone
Sponsor
Mario Negri Institute for Pharmacological Research